Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

The effect of pharmaceutical benefits managers: Is it being evaluated?

The effect of pharmaceutical benefits managers: Is it being evaluated? ANNALS OF INTERNAL MEDICINE Schulman, K. A., Rubenstein, L. E., Abernethy, D. R., Seils, D. M., Sulmasy, D. P. 1996; 124 (10): 906–13

Abstract

Over the last decade, the number of pharmaceutical benefits managers has increased, and their influence has expanded rapidly. These managers now provide prescription drug coverage to more than 100 million Americans. The effect of pharmaceutical benefits managers on health care delivery remains unclear. We review the development of these organizations, their current role in the delivery of pharmaceutical therapies to patients, and their relationship with pharmaceutical manufacturers. We discuss potential advantages and disadvantages of pharmaceutical benefits manager practices and suggest ways in which these organizations can be made more accountable to the employer groups that hire them.

View details for DOI 10.7326/0003-4819-124-10-199605150-00008

View details for Web of Science ID A1996UJ80100008

View details for PubMedID 8610921